Similar Articles

Use of Clozapine in the Treatment-Resistant Schizoprenia

Oğuzhan Kütük

DOI: 10.5606/jebms.2020.75609

Issue: 2020, Volume 1 - Issue 1
894 818

Glucagon-Like Peptide-1 and Psychiatric Disorder

Ayşe Şiva Acar, Oytun Erbaş

DOI: 10.5606/jebms.2021.75645

Issue: 2021, Volume 2 - Issue 2
1629 1237

Neuregulin 1 and Its Roles in Schizophrenia: A Systematic Review

Dildar Savcı, Sultan Karadeniz, Oytun Erbaş

DOI: 10.5606/jebms.2021.75683

Issue: 2021, Volume 2 - Issue 3
528 466

Gluten and Casein: Their Roles in Psychiatric Disorders

Ayşegül Şimal Ulaş, Arzu Çakır, , Oytun Erbaş

DOI: 10.5606/jebms.2022.1003

Issue: 2022, Volume 3 - Issue 1
2737 906

Microglial Effects on Psychiatric Disorders

Hadi Sasani, Oytun Erbaş

DOI: 10.5606/jebms.2022.1005

Issue: 2022, Volume 3 - Issue 1
354 375

Understanding the Role of DISC1 in Psychiatric Disorders

Şeyda Yazıcı, Hadi Sasani, Oytun Erbaş

DOI: 10.5606/jebms.2022.1011

Issue: 2022, Volume 3 - Issue 1
607 330

Association of NOS1AP Variants in Schizophrenia

Ayşenur Saygılı, Oytun Erbaş

DOI: 10.5606/jebms.2022.1013

Issue: 2022, Volume 3 - Issue 1
590 358

N-Methyl D-Aspartic Acid Receptors: An Overview

Dilek Daşdelen, Aylin Kayaaltı, İlknur Altuntaş, Oytun Erbaş

DOI: 10.5606/jebms.2022.1018

Issue: 2022, Volume 3 - Issue 2
1167 357

Schizophrenia Susceptibility Genes

Beyza Nur Akı, Oytun Erbaş

DOI: 10.5606/jebms.2022.1027

Issue: 2022, Volume 3 - Issue
329 337

An Overview of Antipsychotics: Mechanisms of Action

Öznur Demirci, İrem Adar, Oytun Erbaş

DOI: 10.5606/jebms.2023.1047

Issue: 2023, Volume 4 - Issue 1
997 486

N-Acetyl Cysteine: A Potential Adjunctive Therapy in Psychiatric Disorders

Esma Khoja, Oytun Erbaş

DOI: 10.5606/jebms.2024.1088

Issue: 2024, Volume 5 - Issue 2
0 40